According to the research report titled ‘Global Lymphedema Treatment Market 2022-2028’, available with MarketStudyReport, global lymphedema treatment market is slated to grow at 4.8% CAGR over the next six years, amassing a valuation of USD 4,722 million by the year 2028.

Growing incidences of secondary lymphedema, as well as the rising number of facilities are factors acting as growth stimulants for global lymphedema treatment market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042677/  

For those unaware, lymphedema is a chronic ailment that tends to cause swelling in the body's organs and tissues over time. It can impair any part of the body, but it most commonly occurs in the arms or legs. It is caused when the lymphatic system fails to operate adequately.  

Technological advances in the treatment of the disease, coupled with the introduction of novel products are further aiding industry expansion.

Along with this, the report outlines several variables that are likely to hinder market progress during the analysis period. It unveils the opportunities available for the stakeholders to indulge in and optimize their earnings.

Based on form, the market is split into primary lymphedema and secondary lymphedema. In terms of treatment type, global lymphedema treatment industry is categorized into debulking procedures, laser therapy, physiological procedures, drug therapy, compression devices, and others. With respect to end-user, the business sphere is divided into specialty clinics, hospitals, and others. 

From a geographic standpoint, the report states that the market spans across North America, Europe, and Asia Pacific, and conducts a country-level assessment to understand the profit-generating capacity for the review period. 

The prominent players augmenting the competitive scope of worldwide lymphedema treatment market include names like Tactile Systems Technology, Inc., AIROS Medical, Inc., Smith & Nephew plc, Avet Pharmaceuticals, Inc., SIGVARIS AG, Bio Compression Systems, Inc., Mego Afek A.C. Ltd., BSN Medical Srl, Lohmann & Rauscher GmbH & Co. KG, ConvaTec Group plc, Koya Medical, Inc., Herantis Pharma plc, Julius Zorn GmbH, and Huntleigh Healthcare Limited among others.